Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Congenital Anomalies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Active Not RecruitingNCT03975829
What this trial is testing

Pediatric Long-Term Follow-up and Rollover Study

Who this might be right for
Diffuse AstrocytomaAnaplastic AstrocytomaAstrocytoma+20 more
Novartis Pharmaceuticals 163
Not applicableUnknownNCT04878601
What this trial is testing

Innovative Strategies to Increase ART Initiation and Viral Suppression Among HIV-positive Men in Malawi

Who this might be right for
Hiv
University of California, Los Angeles 470
Testing effectiveness (Phase 2)Study completedNCT02236195
What this trial is testing

Study of Mocetinostat in Patients With Urothelial Carcinoma Having Inactivating Alterations of Specific Genes

Who this might be right for
Urothelial Carcinoma
Mirati Therapeutics Inc. 17
Testing effectiveness (Phase 2)Study completedNCT02056665
What this trial is testing

Study to Evaluate the Efficacy and Safety of Minocycline in Angelman Syndrome

Who this might be right for
Angelman Syndrome
Puerta de Hierro University Hospital 32
Not applicableLooking for participantsNCT07630207
What this trial is testing

Vascular Function in Adults With Down Syndrome

Who this might be right for
Down Syndrome (Trisomy 21)
University of Nevada, Las Vegas 24
Not applicableLooking for participantsNCT07561957
What this trial is testing

A Smart Phone Application to Improve Adoption of the 2024 Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease (CKD) Guidelines

Who this might be right for
Chronic Kidney DiseaseProteinuriaBlood Pressure Control+5 more
St. James's Hospital, Ireland 80
Not applicableUnknownNCT06163365
What this trial is testing

Inherited Cancer Early Diagnosis (ICED) Study

Who this might be right for
Li Fraumeni SyndromeLynch SyndromeHereditary Diffuse Gastric Cancer+5 more
Royal Marsden NHS Foundation Trust 100
Early research (Phase 1)Study completedNCT00503490
What this trial is testing

Safety, Pharmacokinetic and Pharmacodynamic Study of MP-376 in Patients With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Amgen 40
Testing effectiveness (Phase 2)Looking for participantsNCT07227207
What this trial is testing

TSRA-196 in Adults With PiZZ Alpha-1 Antitrypsin Deficiency (AATD)

Who this might be right for
Alpha-1 Antitrypsin Deficiency (AATD)
Tessera Therapeutics, Inc. 72
Early research (Phase 1)Study completedNCT06186492
What this trial is testing

Research Study to Evaluate Safety, Tolerability, and Pharmacokinetics of WVE-006 in Healthy Participants With Wild-type AAT Expression (RestorAATion-1)

Who this might be right for
Alpha-1 Antitrypsin Deficiency (AATD)
Wave Life Sciences USA, Inc. 47
Testing effectiveness (Phase 2)Study completedNCT00001034
What this trial is testing

The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients With HIV

Who this might be right for
Cytomegalovirus RetinitisHIV InfectionsGastrointestinal Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 850
Testing effectiveness (Phase 2)Ended earlyNCT01116232
What this trial is testing

Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
Barbara Ann Karmanos Cancer Institute 4
Testing effectiveness (Phase 2)Study completedNCT00742664
What this trial is testing

Behavioral Treatment of Obsessive-Compulsive Symptoms in Youth With Prader-Willi Syndrome: A Pilot Project

Who this might be right for
Prader Willi SyndromeObsessive-compulsive Disorder
University of South Florida 24
Testing effectiveness (Phase 2)WithdrawnNCT05482334
What this trial is testing

Trial to Evaluate Safety and Efficacy of GM-CSF /Sargramostim in Down Syndrome

Who this might be right for
Down Syndrome
University of Colorado, Denver
Early research (Phase 1)Study completedNCT00716014
What this trial is testing

Study of TD101, a Small Interfering RNA (siRNA) Designed for Treatment of Pachyonychia Congenita

Who this might be right for
Pachyonychia Congenita
Pachyonychia Congenita Project 1
Large-scale testing (Phase 3)Study completedNCT02634931
What this trial is testing

Long-term Trial of Topical Sirolimus to Angiofibroma in Patient With Tuberous Sclerosis Complex

Who this might be right for
Tuberous SclerosisAngiofibromaHypomelanotic Macule+1 more
Nobelpharma 94
Early research (Phase 1)Study completedNCT02448264
What this trial is testing

First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BCX7353 in Healthy Western and Japanese Volunteers

Who this might be right for
Hereditary Angioedema
BioCryst Pharmaceuticals 122
Not applicableStudy completedNCT03114371
What this trial is testing

Oxytocin Intranasal Administrations in Children With Prader-Willi Syndrome Aged From 3 to 12 Years

Who this might be right for
Prader-Willi Syndrome
University Hospital, Toulouse 40
Not applicableStudy completedNCT04239521
What this trial is testing

The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata

Who this might be right for
Alopecia AreataDepressive EpisodeRecurrent Depressive Disorder+33 more
Momentum Data 51,955
Large-scale testing (Phase 3)Not Yet RecruitingNCT07290530
What this trial is testing

24-Month Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Syndrome

Who this might be right for
Retinitis Pigmentosa (RP)Usher Syndrome
Nacuity Pharmaceuticals, Inc. 80
Next Page